Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.


Strengths

● Its low valuation, with P/E ratio at 6.55 and 8.47 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The stock, which is currently worth 2021 to 0.31 times its sales, is clearly overvalued in comparison with peers.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.

● As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.

● The company does not generate enough profits, which is an alarming weak point.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.